Glucose Induces β-Cell Apoptosis Via Upregulation of the Fas Receptor in Human Islets
Open Access
- 1 August 2001
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 50 (8) , 1683-1690
- https://doi.org/10.2337/diabetes.50.8.1683
Abstract
In autoimmune type 1 diabetes, Fas–to–Fas-ligand (FasL) interaction may represent one of the essential pro-apoptotic pathways leading to a loss of pancreatic β-cells. In the advanced stages of type 2 diabetes, a decline in β-cell mass is also observed, but its mechanism is not known. Human islets normally express FasL but not the Fas receptor. We observed upregulation of Fas in β-cells of type 2 diabetic patients relative to nondiabetic control subjects. In vitro exposure of islets from nondiabetic organ donors to high glucose levels induced Fas expression, caspase-8 and -3 activation, and β-cell apoptosis. The effect of glucose was blocked by an antagonistic anti-Fas antibody, indicating that glucose-induced apoptosis is due to interaction between the constitutively expressed FasL and the upregulated Fas. These results support a new role for glucose in regulating Fas expression in human β-cells. Upregulation of the Fas receptor by elevated glucose levels may contribute to β-cell destruction by the constitutively expressed FasL independent of an autoimmune reaction, thus providing a link between type 1 and type 2 diabetes.Keywords
This publication has 36 references indexed in Scilit:
- Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the developing and adult rat endocrine pancreasBrain Structure and Function, 2000
- Insulin Resistance Is Not Necessarily an Essential Component of Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2000
- Caspases – controlling intracellular signals by protease zymogen activationBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Improved human islet isolation using a new enzyme blend, liberaseDiabetes, 1997
- Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.Journal of Clinical Investigation, 1996
- Non-Insulin-Dependent Diabetes Mellitus — A Genetically Programmed Failure of the Beta Cell to Compensate for Insulin ResistanceNew England Journal of Medicine, 1996
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992
- Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusionDiabetes, 1989
- Islet Pathology and the Pathogenesis of Type 1 and Type 2 Diabetes mellitus RevisitedPathology and Immunopathology Research, 1985
- Differential volumetry of A,B and D cells in the pancreatic islets of diabetic and nondiabetic subjects.The Tohoku Journal of Experimental Medicine, 1979